Mission Bio is a life sciences company that accelerates discoveries and cures by equipping researchers with the tools they need to improve how we measure and predict our resistance and response to precision therapies. With the Tapestri Platform, the only commercialized platform capable of analyzing DNA and protein simultaneously with single-cell resolution, Mission Bio’s multi-omics approach improves time-to-market for new therapeutics, including innovative cell and gene therapies that provide new pathways to health.
Mission Bio is a biotech company specializing in facilitating the widespread adoption of single-cell DNA and multiomics analysis. Our technology and solutions services offering is centered around our unique Tapestri Platform, which allows scientists and drug developers to analyze the genetic makeup of individual cells and elicit novel, actionable insights. Tapestri is currently enabling advancements in cancer research, drug development, and cell and gene therapy.